Literature DB >> 9727060

Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition.

D J Pinsky1, H Liao, C A Lawson, S F Yan, J Chen, P Carmeliet, D J Loskutoff, D M Stern.   

Abstract

Oxygen deprivation, as occurs during tissue ischemia, tips the natural anticoagulant/procoagulant balance of the endovascular wall to favor activation of coagulation. To investigate the effects of low ambient oxygen tension on the fibrinolytic system, mice were placed in a hypoxic environment with pO2 < 40 Torr. Plasma levels of plasminogen activator inhibitor-1 (PAI-1) antigen, detected by ELISA, increased in a time-dependent fashion after hypoxic exposure (increased as early as 4 h, P < 0.05 vs. normoxic controls), and were accompanied by an increase in plasma PAI-1 activity by 4 h (P < 0.05 vs. normoxic controls). Northern analysis of hypoxic murine lung demonstrated an increase in PAI-1 mRNA compared with normoxic controls; in contrast, transcripts for both tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA) decreased under hypoxic conditions. Immunocolocalization studies identified macrophages as the predominant source of increased PAI-1 within hypoxic lung. Using a transformed murine macrophage line, striking induction of PAI-1 transcripts occurred under hypoxic conditions, due to both increased de novo transcription as well as increased mRNA stability. Consistent with an important role of the fibrinolytic system in hypoxia-induced fibrin accumulation, PAI-1 +/+ mice exposed to hypoxia exhibited increased pulmonary fibrin deposition based upon a fibrin immunoblot, intravascular fibrin identified by immunostaining, and increased accumulation of 125I-fibrinogen/fibrin in hypoxic tissue. In contrast, mice deficient for the PAI-1 gene (PAI-1 -/-) similarly exposed to hypoxic conditions did not display increased fibrin accumulation compared with normoxic PAI-1 +/+ controls. Furthermore, homozygous null uPA (uPA -/-) and tPA (tPA -/-) mice subjected to oxygen deprivation showed increased fibrin deposition compared with wild-type controls. These studies identify enhanced expression of PAI-1 as an important mechanism suppressing fibrinolysis under conditions of low oxygen tension, a response which may be further amplified by decreased expression of plasminogen activators. Taken together, these data provide insight into an important potential role of macrophages and the fibrinolytic system in ischemia-induced thrombosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9727060      PMCID: PMC508957          DOI: 10.1172/JCI307

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  53 in total

1.  Development of an immunoassay for the COOH-terminal region of the gamma chains of human fibrin.

Authors:  B Lahiri; J A Koehn; R E Canfield; S Birken; J Lewis
Journal:  Thromb Res       Date:  1981 Jul 1-15       Impact factor: 3.944

2.  Effects of hypoxia and acidosis on vascular plasminogen activator release in the pig ear perfusion system.

Authors:  L Tappy; J Hauert; F Bachmann
Journal:  Thromb Res       Date:  1984-01-15       Impact factor: 3.944

3.  A sensitive assay for tissue plasminogen activator.

Authors:  M Rånby; B Norrman; P Wallén
Journal:  Thromb Res       Date:  1982-09-15       Impact factor: 3.944

4.  Plasmic degradation of crosslinked fibrin. I. Structural analysis of the particulate clot and identification of new macromolecular-soluble complexes.

Authors:  C W Francis; V J Marder; S E Martin
Journal:  Blood       Date:  1980-09       Impact factor: 22.113

5.  Monocytes and tissue factor promote thrombosis in a murine model of oxygen deprivation.

Authors:  C A Lawson; S D Yan; S F Yan; H Liao; Y S Zhou; J Sobel; W Kisiel; D M Stern; D J Pinsky
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

6.  The PO2 in venous valve pockets: its possible bearing on thrombogenesis.

Authors:  J D Hamer; P C Malone; I A Silver
Journal:  Br J Surg       Date:  1981-03       Impact factor: 6.939

7.  Immunoenzyme histochemical localization of fibrin degradation products in tissues.

Authors:  J J Emeis; J Lindeman; W Nieuwenhuizen
Journal:  Am J Pathol       Date:  1981-06       Impact factor: 4.307

8.  Cardiac preservation is enhanced in a heterotopic rat transplant model by supplementing the nitric oxide pathway.

Authors:  D J Pinsky; M C Oz; S Koga; Z Taha; M J Broekman; A J Marcus; H Liao; Y Naka; J Brett; P J Cannon
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

9.  Plasminogen activator release during venous stasis and exercise as determined by a new specific assay.

Authors:  B Wiman; G Mellbring; M Rånby
Journal:  Clin Chim Acta       Date:  1983-01-24       Impact factor: 3.786

10.  Relative proteolysis of the fibrinogen B beta chain by thrombin and plasmin as a determinant of thrombosis.

Authors:  H L Nossel
Journal:  Nature       Date:  1981-05-14       Impact factor: 49.962

View more
  37 in total

1.  Matrix metalloproteinase-9 and plasminogen activator inhibitor-1 are associated with right ventricular structure and function: the MESA-RV Study.

Authors:  Steven M Kawut; R Graham Barr; W Craig Johnson; Harjit Chahal; Harikrishna Tandri; Aditya Jain; Michael R Bristow; Jorge R Kizer; Emilia Bagiella; Joao A C Lima; David A Bluemke
Journal:  Biomarkers       Date:  2010-10-05       Impact factor: 2.658

2.  Sleep-disordered breathing and prothrombotic biomarkers: cross-sectional results of the Cleveland Family Study.

Authors:  Reena Mehra; Fang Xu; Denise C Babineau; Russell P Tracy; Nancy S Jenny; Sanjay R Patel; Susan Redline
Journal:  Am J Respir Crit Care Med       Date:  2010-05-27       Impact factor: 21.405

Review 3.  Genetic Effects on the Correlation Structure of CVD Risk Factors: Exome-Wide Data From a Ghanaian Population.

Authors:  Nuri Kodaman; Rafal S Sobota; Folkert W Asselbergs; Matthew T Oetjens; Jason H Moore; Nancy J Brown; Melinda C Aldrich; Scott M Williams
Journal:  Glob Heart       Date:  2017-04-10

4.  The effect of acute aerobic exercise on hemostasis in obstructive sleep apnea.

Authors:  Ryan A Martin; Courtney Strosnider; Gabrielle Giersch; Christopher J Womack; Trent A Hargens
Journal:  Sleep Breath       Date:  2017-02-14       Impact factor: 2.816

5.  Characterization of a novel class of polyphenolic inhibitors of plasminogen activator inhibitor-1.

Authors:  Jacqueline M Cale; Shih-Hon Li; Mark Warnock; Enming J Su; Paul R North; Karen L Sanders; Maria M Puscau; Cory D Emal; Daniel A Lawrence
Journal:  J Biol Chem       Date:  2010-01-08       Impact factor: 5.157

Review 6.  Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions.

Authors:  Matteo Cesari; Marco Pahor; Raffaele Antonelli Incalzi
Journal:  Cardiovasc Ther       Date:  2010-07-07       Impact factor: 3.023

Review 7.  The loss of homeostasis in hemostasis: new approaches in treating and understanding acute disseminated intravascular coagulation in critically ill patients.

Authors:  Karen M Hook; Charles S Abrams
Journal:  Clin Transl Sci       Date:  2011-12-07       Impact factor: 4.689

8.  Novel bis-arylsulfonamides and aryl sulfonimides as inactivators of plasminogen activator inhibitor-1 (PAI-1).

Authors:  Nadine C El-Ayache; Shih-Hon Li; Mark Warnock; Daniel A Lawrence; Cory D Emal
Journal:  Bioorg Med Chem Lett       Date:  2009-12-21       Impact factor: 2.823

9.  Sepsis-associated disseminated intravascular coagulation and thromboembolic disease.

Authors:  Nicola Semeraro; Concetta T Ammollo; Fabrizio Semeraro; Mario Colucci
Journal:  Mediterr J Hematol Infect Dis       Date:  2010-08-13       Impact factor: 2.576

10.  Mechanistic characterization and crystal structure of a small molecule inactivator bound to plasminogen activator inhibitor-1.

Authors:  Shih-Hon Li; Ashley A Reinke; Karen L Sanders; Cory D Emal; James C Whisstock; Jeanne A Stuckey; Daniel A Lawrence
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.